出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年7月
勃起不全デバイス市場 : タイプ (真空収縮装置、陰茎インプラント)、ソース (血管、神経疾患)、エンドユーザー (病院、外来手術センター)、地域 (北米、ヨーロッパ、アジア) – 2028年までの世界予測
Erectile Dysfunction Devices Market by Type (Vacuum Constriction Devices, Penile Implants), Source (Vascular, Neurologic disorder), End-user (Hospital, Ambulatory Surgery Center), & Region (North America, Europe, Asia) – Global Forecast to 2028
| ページ数 | 172 |
| 図表数 | 191 |
| 種別 | 英文調査報告書 |
| 価格 |
The global erectile dysfunction devices market is projected to reach USD 2.7 billion by 2028 from USD 1.7 billion in 2023, at a CAGR of 8.8% during the forecast period. The growth of this market is majorly driven by the growing prevalence of tobacco smoking and the rise in neurological disorders such as Alzheimer’s and Parkinson’s. However, issues related to the risk of using these ED devices restrain the growth of the erectile dysfunction devices market.
“The penile implant segment accounted for the highest market share in the erectile dysfunction devices market, by type, during the forecast period.”
Based on the type segment, the erectile dysfunction devices system market is categorized into vacuum constriction devices, penile implants, shockwave therapy, and other device types. The penile implants segment is expected to witness a high market share during the forecast period. This can be attributed to the most successful treatment compared to all other devices, spontaneity, easy to use, and its durability for long-term.
“Clinics accounted for the highest CAGR during the forecast period.”
Based on end users, the erectile dysfunction devices market is segmented into hospitals and ASCs, and clinics, and in 2022, the clinics dominated the market. Factors supporting the growth of clinics include the added advantage of patient privacy and clinics offer individualized care which will attract the patients who are looking for customized setting.
“The North America segment accounted for the highest market share in the erectile dysfunction devices market, by region, during the forecast period.”
Based on the region, the global erectile dysfunction devices market is categorized into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to witness a high market share during the forecast period. The presence of technologically advanced ED devices and the increase in the prevalence of vascular and neurological disorders are supporting the growth of the erectile dysfunction devices market.
Breakdown of primary supply-side interviews by company type, designation, and region:
• By Company Type: Tier 1 (30%), Tier 2 (48%), and Tier 3 (22%)
• By Designation: C-level (28%), Director-level (33%), and Others (39%)
• By Region: North America (32%), Europe (30%), Asia- Pacific (23%), and ROW(15%)
Prominent companies include Boston Scientific Corporation (US), Rigicon, Inc. (US), Coloplast Group (Denmark), Promedon GmbH (Argentina), Zephyr Surgical Implants (Switzerland), Owen Mumford Ltd. (UK), Augusta Medical Systems LLC LLC (US), Shenzhen Huikang Medical Apparatus Co., Ltd. (China), Zimmer MedizinSysteme GmbH (Germany), Medispec (US), MTS Medical UG (Germany), NOVAmedtek (Turkey), Storz Medical AG (Switzerland), The Elator (US), TIMM Medical (US), Ohh-Med Medical Ltd. (Israel), Comphya SA (Switzerland), DirexGroup (Germany), Giddy (US), Advin Health Care (India), and Global Life Technologies Ltd. (US).
Research Coverage
This research report categorizes the erectile dysfunction devices market by type, age group, cause, end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the erectile dysfunction devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the erectile dysfunction devices market. Competitive analysis of upcoming startups in the erectile dysfunction devices market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall erectile dysfunction devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the erectile dysfunction devices market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the erectile dysfunction devices market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the erectile dysfunction devices market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the erectile dysfunction devices market
• Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like Boston Scientific Corporation (US), Rigicon, Inc. (US), Coloplast Group (Denmark), Promedon GmbH (Argentina), and Zephyr Surgical Implants (Switzerland), among others in the erectile dysfunction devices market strategies.
目次
1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.2.1 INCLUSIONS AND EXCLUSIONS 26
1.3 STUDY SCOPE 27
FIGURE 1 ERECTILE DYSFUNCTION DEVICES MARKET: MARKET SEGMENTATION 27
FIGURE 2 ERECTILE DYSFUNCTION DEVICES MARKET: REGIONAL SEGMENTATION 27
1.3.1 YEARS CONSIDERED 28
1.4 CURRENCY CONSIDERED 28
1.5 STAKEHOLDERS 28
1.6 LIMITATIONS 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
FIGURE 3 ERECTILE DYSFUNCTION DEVICES MARKET: RESEARCH DESIGN METHODOLOGY 30
2.1.1 SECONDARY DATA 30
2.1.1.1 Secondary sources 31
2.1.2 PRIMARY DATA 32
TABLE 1 KEY DATA FROM PRIMARY SOURCES 33
FIGURE 4 KEY INDUSTRY INSIGHTS 34
2.1.2.1 Breakdown of primary interviews 34
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 34
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 35
2.2 MARKET SIZE ESTIMATION 35
FIGURE 7 BOTTOM-UP APPROACH: PATIENT-BASED APPROACH 36
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 37
FIGURE 9 ERECTILE DYSFUNCTION DEVICES MARKET: TOP-DOWN APPROACH 37
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 38
FIGURE 10 DATA TRIANGULATION METHODOLOGY 38
2.4 MARKET SHARE ANALYSIS 39
2.5 STUDY ASSUMPTIONS 39
2.6 RISK ASSESSMENT 39
2.7 IMPACT OF RECESSION 40
3 EXECUTIVE SUMMARY 41
FIGURE 11 ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD BILLION) 41
FIGURE 12 ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2023 VS. 2028 (USD BILLION) 42
FIGURE 13 ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2023 VS. 2028 (USD BILLION) 42
FIGURE 14 ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD BILLION) 43
FIGURE 15 REGIONAL SNAPSHOT OF ERECTILE DYSFUNCTION DEVICES MARKET 44
4 PREMIUM INSIGHTS 45
4.1 ERECTILE DYSFUNCTION DEVICES MARKET OVERVIEW 45
FIGURE 16 INCREASING PREVALENCE OF PROSTATE CANCER TO DRIVE MARKET GROWTH 45
4.2 ASIA PACIFIC: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE (2022) 46
FIGURE 17 PENILE IMPLANTS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022 46
4.3 REGIONAL GROWTH OPPORTUNITIES IN ERECTILE DYSFUNCTION DEVICES MARKET 47
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 47
4.4 ERECTILE DYSFUNCTION DEVICES MARKET: REGIONAL MIX 47
FIGURE 19 ASIA PACIFIC MARKET TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 47
4.5 ERECTILE DYSFUNCTION DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES 48
FIGURE 20 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
FIGURE 21 ERECTILE DYSFUNCTION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
5.2.1 DRIVERS 49
5.2.1.1 Increasing prevalence of prostate cancer 49
5.2.1.2 Growing incidence of diabetes, kidney and liver diseases, and atherosclerosis 50
5.2.1.3 High prevalence of tobacco smoking 50
5.2.1.4 Increasing research and development activities 50
5.2.2 RESTRAINTS 51
5.2.2.1 Presence of alternative drug treatments 51
5.2.2.2 Risks associated with use of erectile dysfunction devices 51
5.2.2.3 High cost and lack of reimbursement policies for erectile dysfunction devices 51
5.2.3 OPPORTUNITIES 52
5.2.3.1 Technological advancements 52
5.2.3.2 Rising investments and grants 52
5.2.3.3 Expanding market opportunities in emerging countries 53
5.2.4 CHALLENGES 53
5.2.4.1 Survival of small players and new entrants 53
5.2.4.2 Low awareness regarding prostate health among men 53
5.2.4.3 Shortage of skilled urologists 54
5.3 PRICING ANALYSIS 54
TABLE 2 AVERAGE SELLING PRICE OF DEVICES OFFERED BY KEY PLAYERS 54
5.4 PATENT ANALYSIS 55
FIGURE 22 PATENT ANALYSIS FOR PENILE IMPLANTS (JANUARY 2013–DECEMBER 2022) 55
TABLE 3 LIST OF KEY PATENTS 56
5.5 VALUE CHAIN ANALYSIS 57
FIGURE 23 VALUE CHAIN ANALYSIS OF ERECTILE DYSFUNCTION DEVICES MARKET 57
5.6 SUPPLY CHAIN ANALYSIS 58
FIGURE 24 ERECTILE DYSFUNCTION DEVICES MARKET: SUPPLY CHAIN ANALYSIS 58
5.7 ECOSYSTEM ANALYSIS 59
FIGURE 25 ERECTILE DYSFUNCTION DEVICES MARKET: ECOSYSTEM ANALYSIS 59
5.7.1 ERECTILE DYSFUNCTION DEVICES MARKET: ROLE IN ECOSYSTEM 59
FIGURE 26 KEY PLAYERS IN ERECTILE DYSFUNCTION DEVICES MARKET 60
5.8 PORTER’S FIVE FORCES ANALYSIS 60
TABLE 4 PORTER’S FIVE FORCES ANALYSIS: ERECTILE DYSFUNCTION DEVICES MARKET 60
5.8.1 THREAT OF NEW ENTRANTS 61
5.8.2 THREAT OF SUBSTITUTES 61
5.8.3 BARGAINING POWER OF SUPPLIERS 61
5.8.4 BARGAINING POWER OF BUYERS 61
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 61
5.9 REGULATORY ANALYSIS 61
5.9.1 NORTH AMERICA 62
5.9.1.1 US 62
TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION 62
5.9.1.2 Canada 62
TABLE 6 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 62
5.9.2 EUROPE 63
5.9.3 ASIA PACIFIC 63
5.9.3.1 Japan 63
TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 64
5.9.3.2 China 64
TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES 64
5.9.3.3 India 65
5.10 TRADE ANALYSIS 65
TABLE 9 IMPORT DATA FOR MECHANO-THERAPY APPLIANCES, MASSAGE APPARATUS, AND PSYCHOLOGICAL APTITUDE-TESTING APPARATUS, BY COUNTRY, 2018–2022 (USD MILLION) 65
TABLE 10 EXPORT DATA FOR MECHANO-THERAPY APPLIANCES, MASSAGE APPARATUS, AND PSYCHOLOGICAL APTITUDE-TESTING APPARATUS, BY COUNTRY, 2018–2022 (USD MILLION) 66
5.11 TECHNOLOGY ANALYSIS 66
5.12 KEY CONFERENCES AND EVENTS IN 2023–2024 67
TABLE 11 ERECTILE DYSFUNCTION DEVICES MARKET: LIST OF KEY CONFERENCES AND EVENTS 67
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 68
FIGURE 27 REVENUE SHIFT IN ERECTILE DYSFUNCTION DEVICES MARKET 68
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 68
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 68
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ERECTILE DYSFUNCTION DEVICES 68
TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ERECTILE DYSFUNCTION DEVICES 69
5.14.2 BUYING CRITERIA 69
FIGURE 29 KEY BUYING CRITERIA FOR ERECTILE DYSFUNCTION DEVICES 69
TABLE 13 KEY BUYING CRITERIA FOR ERECTILE DYSFUNCTION DEVICES 69
6 ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE 70
6.1 INTRODUCTION 71
TABLE 14 ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 71
6.2 PENILE IMPLANTS 71
TABLE 15 PENILE IMPLANTS: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 71
TABLE 16 PENILE IMPLANTS: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 72
6.2.1 INFLATABLE IMPLANTS 72
6.2.1.1 Spontaneity of inflatable implants to drive growth 72
TABLE 17 INFLATABLE PENILE IMPLANTS OFFERED BY MARKET PLAYERS 72
TABLE 18 INFLATABLE PENILE IMPLANTS MARKET, BY REGION, 2021–2028 (USD MILLION) 73
6.2.2 MALLEABLE IMPLANTS 73
6.2.2.1 Low maintenance and affordability to drive growth 73
TABLE 19 MALLEABLE PENILE IMPLANTS OFFERED BY MARKET PLAYERS 73
TABLE 20 MALLEABLE PENILE IMPLANTS MARKET, BY REGION, 2021–2028 (USD MILLION) 74
6.3 VACUUM CONSTRICTION DEVICES 74
6.3.1 LOWER COST AND ACCESSIBILITY TO DRIVE GROWTH 74
TABLE 21 VACUUM CONSTRICTION DEVICES OFFERED BY MARKET PLAYERS 75
TABLE 22 VACUUM CONSTRICTION DEVICES: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 75
6.4 SHOCKWAVE THERAPY 75
6.4.1 NON-INVASIVE NATURE OF TREATMENT TO DRIVE GROWTH 75
TABLE 23 SHOCKWAVE THERAPY PRODUCTS OFFERED BY MARKET PLAYERS 76
TABLE 24 SHOCKWAVE THERAPY: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 76
6.5 OTHER DEVICE TYPES 76
TABLE 25 OTHER DEVICE TYPES OFFERED BY MARKET PLAYERS 76
TABLE 26 OTHER DEVICE TYPES: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 77
7 ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP 78
7.1 INTRODUCTION 79
TABLE 27 ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 79
7.2 LESS THAN 40 YEARS 79
7.2.1 INCREASE IN TOBACCO SMOKING TO DRIVE MARKET 79
TABLE 28 LESS THAN 40 YEARS: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 80
7.3 40–60 YEARS 80
7.3.1 INCREASING PREVALENCE OF CVD TO DRIVE GROWTH 80
TABLE 29 40–60 YEARS: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 80
7.4 MORE THAN 60 YEARS 81
7.4.1 HIGH PREVALENCE OF VASCULAR DISORDERS TO DRIVE GROWTH 81
TABLE 30 MORE THAN 60 YEARS: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 81
8 ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE 82
8.1 INTRODUCTION 83
TABLE 31 ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 83
8.2 VASCULAR DISORDERS AND DIABETES 83
8.2.1 VASCULAR DISORDERS AND DIABETES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 83
TABLE 32 VASCULAR DISORDERS AND DIABETES: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 84
8.3 NEUROLOGICAL DISORDERS 84
8.3.1 GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE GROWTH 84
TABLE 33 NEUROLOGICAL DISORDERS: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 85
8.4 OTHER CAUSES 85
TABLE 34 OTHER CAUSES: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 86
9 ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER 87
9.1 INTRODUCTION 88
TABLE 35 ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 88
9.2 HOSPITALS AND ASCS 88
9.2.1 AVAILABILITY OF REIMBURSEMENT AND MULTIDISCIPLINARY CARE IN HOSPITALS TO DRIVE GROWTH 88
TABLE 36 HOSPITALS AND ASCS: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 89
9.3 CLINICS 90
9.3.1 CLINICS SEGMENT TO HOLD LARGER MARKET SHARE 90
TABLE 37 CLINICS: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 90
10 ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION 91
10.1 INTRODUCTION 92
TABLE 38 ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 92
10.2 NORTH AMERICA 92
FIGURE 30 NORTH AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET SNAPSHOT 93
TABLE 39 NORTH AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 40 NORTH AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 41 NORTH AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 42 NORTH AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 94
TABLE 43 NORTH AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 95
TABLE 44 NORTH AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 95
10.2.1 NORTH AMERICA: RECESSION IMPACT 95
10.2.2 US 95
10.2.2.1 US held largest share of North American market in 2022 95
TABLE 45 US: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 96
TABLE 46 US: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 96
TABLE 47 US: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 97
TABLE 48 US: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 97
TABLE 49 US: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 97
10.2.3 CANADA 98
10.2.3.1 Growing government investments and continuous technological developments to drive growth 98
TABLE 50 CANADA: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 98
TABLE 51 CANADA: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 99
TABLE 52 CANADA: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 99
TABLE 53 CANADA: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 99
TABLE 54 CANADA: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 100
10.3 EUROPE 100
10.3.1 EUROPE: RECESSION IMPACT 100
TABLE 55 EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 56 EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 101
TABLE 57 EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 101
TABLE 58 EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 102
TABLE 59 EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 102
TABLE 60 EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 102
10.3.2 GERMANY 103
10.3.2.1 Germany to dominate European market during forecast period 103
TABLE 61 GERMANY: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 62 GERMANY: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 63 GERMANY: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 104
TABLE 64 GERMANY: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 104
TABLE 65 GERMANY: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 104
10.3.3 FRANCE 105
10.3.3.1 Favorable government initiatives to support growth 105
TABLE 66 FRANCE: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 67 FRANCE: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 68 FRANCE: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 106
TABLE 69 FRANCE: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 106
TABLE 70 FRANCE: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 106
10.3.4 UK 107
10.3.4.1 Rising incidence of kidney disorders to drive growth 107
TABLE 71 UK: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 107
TABLE 72 UK: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 107
TABLE 73 UK: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 108
TABLE 74 UK: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 108
TABLE 75 UK: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 108
10.3.5 ITALY 108
10.3.5.1 Aging population to drive growth 108
TABLE 76 ITALY: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 109
TABLE 77 ITALY: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 109
TABLE 78 ITALY: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 109
TABLE 79 ITALY: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 110
TABLE 80 ITALY: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 110
10.3.6 SPAIN 110
10.3.6.1 Growing awareness of ED to drive growth 110
TABLE 81 SPAIN: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 82 SPAIN: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 83 SPAIN: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 111
TABLE 84 SPAIN: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 112
TABLE 85 SPAIN: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 112
10.3.7 REST OF EUROPE 112
TABLE 86 REST OF EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 113
TABLE 87 REST OF EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 113
TABLE 88 REST OF EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 113
TABLE 89 REST OF EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 114
TABLE 90 REST OF EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 114
10.4 ASIA PACIFIC 114
FIGURE 31 ASIA PACIFIC: ERECTILE DYSFUNCTION DEVICES MARKET SNAPSHOT 115
10.4.1 ASIA PACIFIC: RECESSION IMPACT 115
TABLE 91 ASIA PACIFIC: ERECTILE DYSFUNCTION DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 92 ASIA PACIFIC: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 116
TABLE 93 ASIA PACIFIC: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 116
TABLE 94 ASIA PACIFIC: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 117
TABLE 95 ASIA PACIFIC: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 117
TABLE 96 ASIA PACIFIC: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 117
10.4.2 JAPAN 118
10.4.2.1 Japan to hold largest share of Asia Pacific market 118
TABLE 97 JAPAN: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 98 JAPAN: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 119
TABLE 99 JAPAN: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 119
TABLE 100 JAPAN: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 119
TABLE 101 JAPAN: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 120
10.4.3 CHINA 120
10.4.3.1 China to register highest growth in Asia Pacific market during forecast period 120
TABLE 102 CHINA: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 121
TABLE 103 CHINA: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 121
TABLE 104 CHINA: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 121
TABLE 105 CHINA: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 122
TABLE 106 CHINA: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 122
10.4.4 INDIA 122
10.4.4.1 Favorable government initiatives to drive growth 122
TABLE 107 INDIA: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 108 INDIA: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 109 INDIA: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 123
TABLE 110 INDIA: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 124
TABLE 111 INDIA: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 124
10.4.5 REST OF ASIA PACIFIC 124
TABLE 112 ROAPAC: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 113 ROAPAC: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 114 ROAPAC: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 126
TABLE 115 ROAPAC: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 126
TABLE 116 ROAPAC: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 126
10.5 REST OF THE WORLD 127
10.5.1 REST OF THE WORLD: RECESSION IMPACT 127
TABLE 117 REST OF THE WORLD: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 127
TABLE 118 REST OF THE WORLD: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 119 REST OF THE WORLD: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 120 REST OF THE WORLD: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 128
TABLE 121 REST OF THE WORLD: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 128
TABLE 122 REST OF THE WORLD: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 129
10.5.2 LATIN AMERICA 129
10.5.2.1 High prevalence of chronic diseases to drive growth 129
TABLE 123 LATIN AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 124 LATIN AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 130
TABLE 125 LATIN AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 130
TABLE 126 LATIN AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 130
TABLE 127 LATIN AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 131
10.5.3 MIDDLE EAST & AFRICA 131
10.5.3.1 Increasing healthcare spending to drive growth 131
TABLE 128 MIDDLE EAST & AFRICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 129 MIDDLE EAST & AFRICA: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021–2028 (USD MILLION) 132
TABLE 130 MIDDLE EAST & AFRICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 132
TABLE 131 MIDDLE EAST & AFRICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021–2028 (USD MILLION) 132
TABLE 132 MIDDLE EAST & AFRICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 133
11 COMPETITIVE LANDSCAPE 134
11.1 OVERVIEW 134
11.2 MARKET SHARE ANALYSIS 134
TABLE 133 ERECTILE DYSFUNCTION DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER (2022) 134
11.3 COMPANY EVALUATION MATRIX (2022) 135
11.3.1 STARS 135
11.3.2 EMERGING LEADERS 135
11.3.3 PERVASIVE PLAYERS 135
11.3.4 PARTICIPANTS 135
FIGURE 32 ERECTILE DYSFUNCTION DEVICES MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 136
11.4 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 137
11.4.1 PROGRESSIVE COMPANIES 137
11.4.2 STARTING BLOCKS 137
11.4.3 RESPONSIVE COMPANIES 137
11.4.4 DYNAMIC COMPANIES 137
FIGURE 33 ERECTILE DYSFUNCTION DEVICES MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 138
11.5 COMPETITIVE BENCHMARKING 139
TABLE 134 ERECTILE DYSFUNCTION DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS 139
TABLE 135 PRODUCT FOOTPRINT OF KEY PLAYERS 140
TABLE 136 REGIONAL FOOTPRINT OF KEY PLAYERS 141
TABLE 137 ERECTILE DYSFUNCTION DEVICES MARKET: LIST OF KEY START-UPS/SMES 142
11.6 COMPETITIVE SCENARIO 142
11.6.1 KEY PRODUCT LAUNCHES 142
TABLE 138 KEY PRODUCT LAUNCHES, JANUARY 2020–JUNE 2023 142
11.6.2 KEY DEALS 143
TABLE 139 KEY DEALS, JANUARY 2020–JUNE 2023 143
11.6.3 OTHER KEY DEVELOPMENTS 144
TABLE 140 OTHER KEY DEVELOPMENTS, JANUARY 2020–JUNE 2023 144
12 COMPANY PROFILES 145
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1 KEY PLAYERS 145
12.1.1 BOSTON SCIENTIFIC CORPORATION 145
TABLE 141 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 145
FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022) 146
12.1.2 COLOPLAST GROUP 148
TABLE 142 COLOPLAST GROUP: COMPANY OVERVIEW 148
FIGURE 35 COLOPLAST GROUP: COMPANY SNAPSHOT (2022) 149
12.1.3 RIGICON, INC. 151
TABLE 143 RIGICON, INC.: COMPANY OVERVIEW 151
TABLE 144 RIGICON, INC.: PRODUCT LAUNCHES 151
12.1.4 PROMEDON GMBH 153
TABLE 145 PROMEDON GMBH: COMPANY OVERVIEW 153
12.1.5 ZEPHYR SURGICAL IMPLANTS 154
TABLE 146 ZEPHYR SURGICAL IMPLANTS: COMPANY OVERVIEW 154
12.1.6 OWEN MUMFORD LTD. 156
TABLE 147 OWEN MUMFORD LTD.: COMPANY OVERVIEW 156
TABLE 148 OWEN MUMFORD LTD.: OTHER DEVELOPMENTS 156
12.1.7 AUGUSTA MEDICAL SYSTEMS LLC 157
TABLE 149 AUGUSTA MEDICAL SYSTEMS LLC: COMPANY OVERVIEW 157
12.1.8 SHENZHEN HUIKANG MEDICAL APPARATUS CO., LTD. 158
TABLE 150 SHENZHEN HUIKANG MEDICAL APPARATUS CO., LTD.: COMPANY OVERVIEW 158
TABLE 151 SHENZHEN HUIKANG MEDICAL APPARATUS CO., LTD.: DEALS 158
TABLE 152 SHENZHEN HUIKANG MEDICAL APPARATUS CO., LTD.: OTHER DEVELOPMENTS 159
12.1.9 ZIMMER MEDIZINSYSTEME GMBH 160
TABLE 153 ZIMMER MEDIZINSYSTEME GMBH: COMPANY OVERVIEW 160
12.1.10 MEDISPEC LTD. 161
TABLE 154 MEDISPEC LTD.: COMPANY OVERVIEW 161
12.1.11 MTS MEDICAL UG 162
TABLE 155 MTS MEDICAL UG: COMPANY OVERVIEW 162
TABLE 156 MTS MEDICAL UG: DEALS 163
12.2 OTHER PLAYERS 164
12.2.1 NOVAMEDTEK 164
12.2.2 STORZ MEDICAL AG 165
12.2.3 THE ELATOR 165
12.2.4 TIMM MEDICAL 166
12.2.5 OHH-MED MEDICAL LTD. 167
12.2.6 COMPHYA SA 167
12.2.7 DIREXGROUP 168
12.2.8 ADVIN HEALTH CARE 168
12.2.9 GIDDY 169
12.2.10 GLOBAL LIFE TECHNOLOGIES LTD. 169
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 170
13.1 DISCUSSION GUIDE 170
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 174
13.3 CUSTOMIZATION OPTIONS 176
13.4 RELATED REPORTS 176
13.5 AUTHOR DETAILS 177